2021
DOI: 10.1136/ejhpharm-2021-002869
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the impact of the addition of a heart failure prescribing pharmacist to consultant-led heart failure ward round at a tertiary hospital

Abstract: Objective Pharmacists attending general medical post-admission ward rounds is established good practice. However, there is a lack of evidence on the impact of specialist heart failure (HF) prescribing pharmacists on consultant HF ward rounds. The aim of this study was to evaluate the impact on prescribing when a specialist HF prescribing pharmacist attended inpatient HF ward rounds. Methods A prospective service evaluation completed at a tertiary hospital between September and December 2020. The same HF prescr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 14 publications
1
3
0
Order By: Relevance
“…These results are consistent with other studies that included an evaluation of the prescriptive appropriateness of chronic pharmacological therapies [36,37]. This underlines the importance of involving a drug expert, such as a pharmacist or a researcher on drug utilization, in the patient care pathway: although some of the evidence [40][41][42][43][44] associated the presence of a drug expert with positive health outcomes, this figure is still not systematically involved in clinical practice at a national level.…”
Section: Discussionsupporting
confidence: 88%
“…These results are consistent with other studies that included an evaluation of the prescriptive appropriateness of chronic pharmacological therapies [36,37]. This underlines the importance of involving a drug expert, such as a pharmacist or a researcher on drug utilization, in the patient care pathway: although some of the evidence [40][41][42][43][44] associated the presence of a drug expert with positive health outcomes, this figure is still not systematically involved in clinical practice at a national level.…”
Section: Discussionsupporting
confidence: 88%
“…The present study shows that well-recognised Goals of participation in WRs, with a median and IQR of 15 (13–15), and ‘clinical pharmacists in the multidisciplinary team help improve overall patient outcome and quality of care during a WR,' were identified more positively among clinical pharmacists who participated in 12 months of internship. Clinical pharmacists’ participation in hospital wards has led to improved clinical outcomes for patients with various diseases, including chronic non-communicable and infectious diseases ( Campbell et al, 2023 ; Thomas et al, 2014; Bullock et al, 2020 ; Kubas et al, 2020 ). Recently, this was clearly supported by their participation during the COVID-19 pandemic and the critical role they played ( Baudouin et al, 2023 ; Alshakka et al, 2022 ).…”
Section: Discussionmentioning
confidence: 99%
“…Our current survey expands on the understanding that clinical pharmacists’ involvement in WR also requires special Skills and Capabilities in the form of professional confidence, and clinical pharmacists involved in 12-month internships reported having more professional confidence to contribute effectively to WR. A cornerstone of clinical pharmacists’ participation in WRs is the identification, solving, and prevention of drug-related problems ( Campbell et al, 2023; Thomas et al, 2014; Bullock et al, 2019; Bullock et al, 2020; Kubas et al, 2020 ). In the present survey, almost all Yemeni clinical pharmacists showed they could solve medication-related problems and perform this critical clinical task in WR.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation